The PROACT Trial

Update: 2025-03-05

Description

Talking with C. Michael Gibson, David Austin reviews the phase III trial of enalapril for anthracycline-induced cardiotoxicity in lymphoma and breast cancer patients.

Comments

In Channel

The NOTION-3 Trial

2025-09-0317:21

TMVR in the Heart Failure Paradigm

2025-08-1514:12

The ABYSS Trial

2025-08-1306:02

Patient Selection and Treatment Goals

2025-08-1115:20

Women's Health Study: Biomarkers

2025-08-0609:51

Echocardiography and Quality Data

2025-08-0422:10

Insights on Intrepid 2-Yr Mitral TF EFS

2025-07-3016:01

New ESC Guidelines for AF

2025-07-2320:07

The STEEER-AF Trial

2025-07-0905:57

The EPIC-CAD Trial

2025-07-0212:08

Acute Coronary Care in Ethiopia

2025-06-1812:08

The POPular PAUSE TAVI Trial

2025-06-0404:47

The SENIOR-RITA Trial

2025-05-2110:10

The REDUCE-AMI Trial

2025-05-0712:50

The EARTH-STEMI Trial

2025-04-1606:16

The SCOFF Trial

2025-04-0907:23

The RESHAPE-HF2 and MATTERHORN Trials

2025-04-0216:50

The EMPACT-MI Trial

2025-03-1906:23

The PROACT Trial

2025-03-0504:24

The ORBITA-COSMIC Trial

2025-02-1012:45

00:00

#box-pro-ellipsis-175800647531565{-webkit-line-clamp:2;}The PROACT Trial

The PROACT Trial

TCTMD

The PROACT Trial